SRx Health stockholders approve 25x share increase and up to 85:1 reverse split

SRx Health Solutions, Inc.

Authorized shares increased from 200M to 5B; additional reverse split range 15:1 to 85:1 approved.
Issuance above 19.99% outstanding authorized under ELOC Purchase Agreement and July 2025 SPA.
Bylaw quorum lowered from majority to one-third of outstanding shares.
Written consent holders with 51.20% voting power approved all matters; no opposition.
Additional reverse split must occur by March 31, 2026 at Board's discretion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.